why choose us

First received: December 2, 2022

Clinical Trial: Biologics in Management of Inflammatory Bowel Disease in Egyptian Patients

Study Status: Completed

Recruit Status: Completed

Condition: IBD

Study Type: Observational


Official Title: Adalimumab Versus Ustekinumab in Management of Inflammatory Bowel Disease in Egyptian Patients

Brief Summary: Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), is a chronic inflammatory relapsing disorder affecting the gastrointestinal tract and is characterized by a progressive and unpredictable disease course.The two goals of therapy are the achievement of remission (induction) and the prevention of disease flares (maintenance). Medical therapy for IBD has advanced dramatically in the last decade with the introduction of targeted biologic therapies including…

Read more